C5a suppresses the production of IL-12 by IFN-γ-primed and lipopolysaccharide-challenged human monocytes

Journal of Immunology

Volumn 162, Issue 11, 1999, Pages 6763-6769

  Wittmann, Miriam ^a   Zwirner, Jörg ^b   Larsson, Vivi Ann ^a   Kirchhoff, Konstanze ^a   Begemann, Gabriele ^a   Kapp, Alexander ^a   Götze, Otto ^b   Werfel, Thomas ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; LIPOPOLYSACCHARIDE;

ARTICLE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; CELLS, CULTURED; COMPLEMENT C5A; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LIPOPOLYSACCHARIDES; MONOCYTES;

EID: 0033152662     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Goldstein, I. M. 1992. Complement-biologically active products. In Inflammation: Basic Principles and Clinical Correlates, 2nd Ed. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 63.
2. Huey, R., and T. E. Hugli. 1987. C5a receptor. Methods Enzymol. 150:615.
3. Werfel, T., M. Oppermann, M. Schulze, G. Krieger, M. Weber, and O. Götze. 1992. Binding of fluorescein-labeled anaphylatoxin C5a to human peripheral blood, spleen, and bone marrow leukocytes. Blood 79:152.
4. Montz, H., K. C. Koch, R. Zierz, and O. Götze. 1991. The role of C5a in interleukin-6 production induced by lipopolysaccharide or interleukin-1. Immunology 74:373.
5. Morgan, E. L., S. Sanderson, W. Scholz, D. J. Noonan, W. O. Weigle, and T. E. Hugli. 1992. Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis. J. Immunol. 148:3937.
6. Schindler, R., G. Lonnemann, S. Shaldon, K. M. Koch, and C. A. Dinarello. 1990. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int. 37:85.
7. Ember, J. A., S. D. Sanderson, T. E. Hugli, and E. L. Morgan. 1994. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144:393.
8. Werfel, T., G. Sonntag, M. H. Weber, and O. Götze. 1991. Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fcγ-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a. J. Immunol. 147:3909.
9. Germann, T., and E. Rude. 1995. Interleukin-12. Int. Arch. Allergy Immunol. 108:103.
10. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Nabavi, A. G. Wolitzky, P. M. Quinn, and P. C. Familletti. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143.
11. Hayes, M. P., J. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646.
12. Gately, M. K., B. B. Desai, A. G. Wolitzky, P. M. Quinn, C. M. Dwyer, F. J. Podlaski, P. C. Familletti, F. Sinigaglia, R. Chizonnite, and U. Gubler. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
13. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
14. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, and R. M. Hewick. 1991. Cloning of cDNA for natural kilter cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
15. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
16. Trinchieri, G. 1993. Interleukin-12 and its role in the generation of TH1 cells. Immunol. Today 14:335.
17. Trinchieri, G., and F. Gerosa. 1996. Immunoregulation by interleukin-12. J. Leukocyte Biol. 56:505.
18. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyle-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
19. Scott, P. 1993. IL-12: Initiation cytokine for cell-mediated immunity. Science 260:496.
20. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
21. D'Andrea, A., M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041.
22. Snijders, A., C. M. Hilkens, T. C. Van der Pouw Kraan, M. Engel, L. A. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207.
23. Van der Pouw Kraan, T. C., L. C. Boeije, A. Snijders, R. J. Smeenk, J. Wijdenes, and L. A. Aarden. 1996. Regulation of IL-12 production by human monocytes and the influence of prostaglandin E2. Ann. NY Acad. Sci. 795:147.
24. D'Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, and G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor a production. J. Exp. Med. 181:537.
25. Oppermann, M., U. Hopken, and O. Götze. 1992. Assessment of complement activation in vivo. Immunopharmacology 24:119.
26. Rothermel, E., J. Zwirner, T. Vogt, S. Rabini, and O. Götze. 1997. Molecular cloning and expression of the functional rat C5a receptor. Mol. Immunol. 34:877.
27. Gerrard, T. L., C. H. Jurgensen, and A. S. Fauci. 1983. Differential effect of monoclonal anti-DR antibody on monocytes in antigen-and mitogen-slimulated responses: mechanism of inhibition and relationship to interleukin 1 secretion. Cell. Immunol. 82:394.
28. Wittmann, M., V. Larsson, G. Begemann, P. Schmidt, A. Kapp, and T. Werfel. 1998. Selective suppression of IL-12 (p70) production by human monocytes after preincubation with lipopolysaccharide (LPS) or the antitumor agent paclitaxel (PTXL). J. Allergy Clin. Immunol. 101:S20.
29. Jung, T., U. Schauer, C. Heusser, C. Neumann, and C. Rieger. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159:197.
30. + cells and react with a desmosomal antigen in human skin. J. Immunol. 157:1729.
31. Gerard, C., and T. E. Hugli. 1981. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc. Natl. Acad. Sci. USA 78:1833.
32. Huey, R., C. M. Bloor, M. S. Kawahara, and T. E. Hugli. 1983. Potentiation of the anaphylatoxins in vivo using an inhibitor of the serum carboxypeptidase N (SCPN). I. Lethality and pathological effects on pulmonary tissue. Am. J. Pathol. 112:48.
33. Bergh, K., and O. J. Iversen. 1992. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitopespecific sandwich-ELISA for the quantification of C5a des Arg in plasma. J. Immunol. Methods 152:79.
34. Müller, T. F., M. Kraus, C. Neumann, and H. Lange. 1997. Detection of renal allograft rejection by complement components C5a and TCC in plasma and urine. J. Lab. Clin. Med. 129:62.
35. Müller, T. F., C. M. Neumann, C. Greb, M. Kraus, and H. Lange. 1996. The anaphylatoxin C5a, a new parameter in the diagnosis of renal allograft rejection. Transplant. Int. 9:S58.
36. Lauener, R. P., S. M. Goyert, R. S. Geha, and D. Vercelli. 1990. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur. J. Immunol. 20:2375.
37. + T cells. Am. NY Acad. Sci. 795:349.
38. Mattner, F., S. Fischer, S. Guckes, S. Jin, H. Kaulen, E. Schmitt, E. Rude, and T. Germann. 1993. The inlerleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer. Eur. J. Immunol. 23:2202.
39. Freudenberg, M. A., and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56:1352.
40. 7-induced nitric oxide synthase gene expression in primary mouse macrophages. J. Immunol. 151:301.
41. Granowitz, E. V., R. Porat, J. W. Mier, S. F. Orencole, G. Kaplanski, E. A. Lynch, K. Ye, E. Vannier, S. M. Wolff, and C. A. Dinarello. 1993. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 151:1637.
42. Mengozzi, M., G. Fantuzzi, M. Sironi, M. Bianchi, M. Fratelli, G. Peri, S. Bernasconi, and P. Ghezzi. 1993. Early down-regulation of TNF production by LPS tolerance in human monocytes: comparison with IL-1β, IL-6, and IL-8. Lymphokine Cytokine Res. 12:231.
43. Takasuka, N., T. Tokunaga, and K. S. Akagawa. 1991. Preexposure of macrcphages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J. Immunol. 146:3824.
44. Ziegler-Heitbrock, H. W., M. Frankenberger, and A. Wedel. 1995. Tolerance to lipopolysaccharide in human blood monocytes. Immunobiology 193:217.
45. Ziegler-Heitbrock, H. W., M. Blumenstein, E. Kafferlein, D. Kieper, I. Petersmann, S. Endres, W. A. Flegel, H. Northoff, G. Riethmuller, and J. G. Haas. 1992. In vitro desensitization to lipopolysaccharide suppresses tumour necrosis factor, interleukin-1 and inierleukin-6 gene expression in a similar fashion. Immunology 75:264.
46. Cavaillon, J. M., C. Fitting, and N. Haeffner-Cavaillon. 1990. Recombinam C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur. J. Immunol. 20:253.
47. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
48. Marth, T., and B. L. Kelsall. 1997. Regulation of interleukin-12 by complement receptor 3 signaling. J. Exp. Med. 185:1987.
49. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977.
50. Monk, P. N., and L. J. Partridge. 1993. Characterization of a complement-fragment-C5a-stimulated calcium-influx mechanism in U937 monocytic cells. Biochem. J. 295:679.